Phase II Studies in Soft Tissue Sarcoma: Time for Reappraisal

E-resources

PDF

Full text

Peer reviewed Open access

Phase II Studies in Soft Tissue Sarcoma: Time for Reappraisal

Sleijfer, Stefan

The oncologist (Dayton, Ohio), 2012, Volume: 17, Issue: 2

Journal Article

A phase II study with sorafenib in patients with angiosarcoma conducted by the French Sarcoma Group, and published in this issue of The Oncologist, is evaluated. The importance of proper design and conduct of phase II trials is stressed.

Keep searching

Author

Sleijfer, Stefan

Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.

Year	Impact factor		Edition		Category		Classification
Year	JCR	SNIP	JCR	SNIP	JCR	SNIP	JCR	SNIP

Links to authors' personal bibliographies	Links to information on researchers in the SICRIS system

Source: Personal bibliographies and: SICRIS

Upload image

Shelf entry

Adding material to shelf was successful.

Adding material to shelf failed.

It was not necessary to add the material to the shelf.

Permalink

E-mail

Impact factor

Select the library membership card:

DRS, in which the journal is indexed

Citations

Theme